Skip to main content

Better Therapeutics stock surges on ‘big milestone’ after FDA approves smartphone-based diabetes treatment

Better Therapeutics shares surged in the extended session Monday after the company got FDA approval for its smartphone-based behavioral diabetes therapy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.